Ortin Global (BOM:539287) Piotroski F-Score: 2 (As of Jul. 09, 2026) — 50% Below Median


BOM:539287 Ortin Global Ltd BOM:539287
42 GF Score
Price ₹17.00
GF Value ₹2.54
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ortin Global Piotroski F-Score?

Ortin Global BOM:539287 +3.16% 42 Piotroski F-Score is 2 as of Jul. 09, 2026, which is 50% below its 10-year median of 4.00. GuruFocus rates BOM:539287 with a GF Score™ of 42/100 and a GF Value™ of ₹2.54 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 980 Drug Manufacturers companies, Ortin Global ranks worse than 91.22% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ortin Global has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Ortin Global's Piotroski F-Score or its related term are showing as below:

BOM:539287' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 8
Current: 2

During the past 13 years, the highest Piotroski F-Score of Ortin Global was 8. The lowest was 2. And the median was 4.

Ortin Global  (BOM:539287) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ortin Global Piotroski F-Score Related Terms


Ortin Global Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Ortin Global's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortin Global Piotroski F-Score Chart

Ortin Global Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 3.00 4.00 2.00

Ortin Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 0.00 0.00 0.00 2.00

BOM:539287 vs ZTS, UTHR: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Global Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Ortin Global's Piotroski F-Score falls into.


BOM:539287
42GF Score
Ortin Global Ltd BOM:539287
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹-7.40 Mil.
Cash Flow from Operations was ₹-5.60 Mil.
Revenue was ₹1.01 Mil.
Gross Profit was ₹0.04 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (37.809 + 46.472) / 2 = ₹42.1405 Mil.
Total Assets at the begining of this year (Mar25) was ₹37.81 Mil.
Long-Term Debt & Capital Lease Obligation was ₹10.05 Mil.
Total Current Assets was ₹38.37 Mil.
Total Current Liabilities was ₹24.05 Mil.
Net Income was ₹-8.46 Mil.

Revenue was ₹3.42 Mil.
Gross Profit was ₹1.28 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (66.643 + 37.809) / 2 = ₹52.226 Mil.
Total Assets at the begining of last year (Mar24) was ₹66.64 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2.50 Mil.
Total Current Assets was ₹33.42 Mil.
Total Current Liabilities was ₹15.53 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ortin Global's current Net Income (TTM) was -7.40. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ortin Global's current Cash Flow from Operations (TTM) was -5.60. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-7.404/37.809
=-0.19582639

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-8.464/66.643
=-0.12700509

Ortin Global's return on assets of this year was -0.19582639. Ortin Global's return on assets of last year was -0.12700509. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ortin Global's current Net Income (TTM) was -7.40. Ortin Global's current Cash Flow from Operations (TTM) was -5.60. ==> -5.60 > -7.40 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=10.05/42.1405
=0.23848792

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=2.5/52.226
=0.04786888

Ortin Global's gearing of this year was 0.23848792. Ortin Global's gearing of last year was 0.04786888. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=38.374/24.051
=1.59552617

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=33.423/15.534
=2.15160294

Ortin Global's current ratio of this year was 1.59552617. Ortin Global's current ratio of last year was 2.15160294. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ortin Global's number of shares in issue this year was 8.136. Ortin Global's number of shares in issue last year was 8.138. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.04/1.005
=0.039801

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1.276/3.422
=0.37288136

Ortin Global's gross margin of this year was 0.039801. Ortin Global's gross margin of last year was 0.37288136. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1.005/37.809
=0.02658097

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=3.422/66.643
=0.05134823

Ortin Global's asset turnover of this year was 0.02658097. Ortin Global's asset turnover of last year was 0.05134823. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+1+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ortin Global has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
Ortin Global (BOM:539287) has a Piotroski F-Score of 2 as of Jul. 09, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ortin Global and its competitors. This is 50% below median its historical median of 4.00. Over the past decade, Ortin Global's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Ortin Global ranks #894 out of 980 companies in the Drug Manufacturers industry, placing it in the top 91.2%.
Is Ortin Global's Piotroski F-Score too high?
Ortin Global's current Piotroski F-Score of 2 is 50% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Ortin Global's value of 2 is 60% below this industry median. Based on the distribution chart, Ortin Global ranks #894 out of 980 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ortin Global has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ortin Global's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ortin Global ranks #894 out of 980 companies for Piotroski F-Score. This places Ortin Global in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Ortin Global's value of 2 is 60% below this benchmark. Historically, Ortin Global's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Ortin Global has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 980 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ortin Global's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ortin Global and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ortin Global's current Piotroski F-Score is 2, which is 50% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortin Global stock overvalued right now?
Based on GuruFocus' analysis, Ortin Global (BOM:539287) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.54, compared to a current price of ₹17.00 — trading 569.3% above its estimated fair value. The current Piotroski F-Score is 2, which is 50% below median its 10-year median of 4.00 and 60% below the Drug Manufacturers industry median of 5.00. Ortin Global's overall GF Score™ is 42/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ortin Global (BOM:539287), the current Piotroski F-Score is 2 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ortin Global (BOM:539287) Overvalued in 2026?

Based on GuruFocus' analysis, Ortin Global stock appears to be overvalued. The current stock price of ₹17.00 is trading 569.3% above its estimated GF Value™ of ₹2.54. GuruFocus considers Ortin Global to be Significantly Overvalued.

Key valuation signals for BOM:539287:

  • Piotroski F-Score: 2 (50% below median its 10-year median of 4.00)
  • GF Value™: ₹2.54 vs. price of ₹17.00 (569.3% above fair value)
  • GF Score™: 42/100 with 8 warning signs
  • Industry Position: 60% below the Drug Manufacturers median (#894 of 980)

No single metric tells the full story. See the BOM:539287 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ortin Global Business Description

Other Exchanges ORTINGLOBE:India
Address G Block, Plot No. C-66, 9th Floor, 915, One BKC, Bandra Kurla Complex, Bandra East, Mumbai, MH, IND, 400051
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
42GF Score

Get the complete analysis for BOM:539287

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹17.00
Price
₹2.54
GF Value